{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:15:24Z","timestamp":1790615724650,"version":"4.1.0"},"reference-count":71,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cancer and its treatments frequently compromise skin integrity, leading to xerosis, pruritus, dermatitis, radiation-induced skin damage, and secondary infections. These cutaneous adverse events (cAEs) are not merely superficial; they profoundly impact patient quality of life (QoL), contributing to physical discomfort, psychosocial distress, and poorer treatment adherence. Even mild skin toxicities elevate dermatology-specific QoL measures, affecting mood and social function. Additionally, new targeted therapies, such as daraxonrasib\u2014a KRAS inhibitor under development for pancreatic cancer\u2014can cause a dose-limiting acneiform facial rash.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this study, relevant literature on skin care in cancer patients was identified using PubMed. Evidence from clinical studies, reviews, and expert guidelines was summarized.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Evidence supports proactive skincare with gentle pH-balanced cleansers, ceramide- or urea-based moisturizers, and broad-spectrum photoprotection to lessen symptom severity and improve QoL. Sun protection remains essential because chemotherapy and immunomodulatory therapies increase photosensitivity, accelerate photoaging, and raise the risk of secondary skin cancers. Supportive skincare interventions have also shown emotional and functional benefits, including improved mood and self-image during chemotherapy and radiation treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Despite strong data supporting moisturization, barrier repair, and photoprotection, oncologic treatment plans often overlook these interventions. By integrating dermatologic education and skincare maintenance into standard oncologic practice, we can minimize cAEs, foster treatment compliance, and enhance patients\u2019 physical comfort and psychosocial well-being. This narrative review synthesizes mechanistic insights, clinical evidence, and practical recommendations for oncologists to champion comprehensive skincare in all cancer patients, whether directly affected by skin issues or not.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/oncolo\/oyag194","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T11:40:15Z","timestamp":1780141215000},"source":"Crossref","is-referenced-by-count":2,"title":["Skin health in oncology: evidence-based skin care for cancer patients"],"prefix":"10.1093","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0059-2619","authenticated-orcid":false,"given":"Alexander","family":"Kaminsky","sequence":"first","affiliation":[{"name":"Columbia University Vagelos College of Physicians and Surgeons , New York, NY 10032,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Suhl","sequence":"additional","affiliation":[{"name":"Columbia University Vagelos College of Physicians and Surgeons , New York, NY 10032,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoni","family":"Sacknovitz","sequence":"additional","affiliation":[{"name":"Columbia University Vagelos College of Physicians and Surgeons , New York, NY 10032,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary K","family":"Schwartz","sequence":"additional","affiliation":[{"name":"Case Comprehensive Cancer Center , Cleveland, OH 44106,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandhya","family":"Deverapalli","sequence":"additional","affiliation":[{"name":"Tufts Medical Center , Boston, MA 02111,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0981-3513","authenticated-orcid":false,"given":"Larisa J","family":"Geskin","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Columbia University Irving Medical Center , New York, NY 10032,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"key":"2026062512014234100_oyag194-B1","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/nrc1970","article-title":"Mechanisms of cutaneous toxicities to EGFR inhibitors","volume":"6","author":"Lacouture","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"2026062512014234100_oyag194-B2","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.soncn.2006.04.004","article-title":"Evidence-based skin care management in radiation therapy","volume":"22","author":"McQuestion","year":"2006","journal-title":"Semin Oncol Nurs"},{"key":"2026062512014234100_oyag194-B3","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1007\/s00520-009-0769-1","article-title":"Unanticipated toxicities from anticancer therapies: survivors\u2019 perspectives","volume":"18","author":"Gandhi","year":"2010","journal-title":"Support Care Cancer"},{"key":"2026062512014234100_oyag194-B4","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0190-9622(99)70488-3","article-title":"Mucocutaneous reactions to chemotherapy","volume":"40","author":"Susser","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"2026062512014234100_oyag194-B5","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00520-007-0318-8","article-title":"Chemotherapy-induced dermatological toxicity: frequencies and impact on quality of life in women\u2019s cancers. Results of a prospective study","volume":"16","author":"Hackbarth","year":"2008","journal-title":"Support Care Cancer"},{"key":"2026062512014234100_oyag194-B6","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/j.1524-4741.2007.00512.x","article-title":"The role of health-related quality of life in early discontinuation of chemotherapy for breast cancer","volume":"13","author":"Richardson","year":"2007","journal-title":"Breast J"},{"key":"2026062512014234100_oyag194-B7","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/bjd.19298","article-title":"Current measures are not sufficient: an interview-based qualitative assessment of quality of life in cutaneous T-cell lymphoma","volume":"184","author":"Bhat","year":"2021","journal-title":"Br J Dermatol"},{"key":"2026062512014234100_oyag194-B8","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1600-0625.2008.00786.x","article-title":"The skin: an indispensable barrier","volume":"17","author":"Proksch","year":"2008","journal-title":"Exp Dermatol"},{"key":"2026062512014234100_oyag194-B9","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/j.jid.2021.02.014","article-title":"Acidic pH is required for the multilamellar assembly of skin barrier lipids in vitro","volume":"141","author":"Nov\u00e1\u010dkov\u00e1","year":"2021","journal-title":"J Invest Dermatol"},{"key":"2026062512014234100_oyag194-B10","doi-asserted-by":"publisher","first-page":"182","DOI":"10.23937\/2377-3634\/1410182","article-title":"Pathophysiology of the skin in type 1 and type 2 diabetes and emerging therapeutic opportunities","volume":"11","author":"Poonja","year":"2024","journal-title":"Int J Diabetes Clin Res"},{"key":"2026062512014234100_oyag194-B11","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s40257-020-00531-1","article-title":"The skin microbiome: a new actor in inflammatory acne","volume":"21","author":"Dr\u00e9no","year":"2020","journal-title":"Am J Clin Dermatol"},{"key":"2026062512014234100_oyag194-B12","doi-asserted-by":"publisher","first-page":"adv00544","DOI":"10.2340\/00015555-3911","article-title":"Management of mycosis fungoides with topical chlormethine\/mechlorethamine gel: a Columbia University Cutaneous Lymphoma Center experience","volume":"101","author":"Garcia-Saleem","year":"2021","journal-title":"Acta Derm Venereol"},{"key":"2026062512014234100_oyag194-B13","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/phpp.12533","article-title":"Photosensitivity and cancer immune-targeted therapies","volume":"36","author":"Lembo","year":"2020","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"2026062512014234100_oyag194-B14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/jdv.18200","article-title":"Anticancer treatments and photosensitivity","volume":"36","author":"Sibaud","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026062512014234100_oyag194-B15","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.jaad.2019.01.077","article-title":"Incidence and risk of developing photosensitivity with targeted anticancer therapies","volume":"81","author":"Ciccolini","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"2026062512014234100_oyag194-B16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.0022-202X.2005.23668.x","article-title":"Stratum corneum defensive functions: an integrated view","volume":"125","author":"Elias","year":"2005","journal-title":"J Invest Dermatol"},{"key":"2026062512014234100_oyag194-B17","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1159\/000094670","article-title":"The pH of the skin surface and its impact on the barrier function","volume":"19","author":"Schmid-Wendtner","year":"2006","journal-title":"Skin Pharmacol Physiol"},{"key":"2026062512014234100_oyag194-B18","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/s0190-9622(97)70140-3","article-title":"Optimal ratios of topical stratum corneum lipids improve barrier recovery in chronologically aged skin","volume":"37","author":"Zettersten","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"2026062512014234100_oyag194-B19","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.jaad.2014.03.019","article-title":"Chemotherapy-induced hand-foot syndrome and nail changes: a review of clinical presentation, etiology, pathogenesis, and management","volume":"71","author":"Miller","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"2026062512014234100_oyag194-B20","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1056\/NEJMoa2212419","article-title":"Adagrasib with or without cetuximab in colorectal cancer with mutated KRAS G12C","volume":"388","author":"Yaeger","year":"2023","journal-title":"N Engl J Med"},{"key":"2026062512014234100_oyag194-B21","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.jaad.2022.12.048","article-title":"Cutaneous immune-related adverse events are associated with longer overall survival in advanced cancer patients on immune checkpoint inhibitors: a multi-institutional cohort study","volume":"88","author":"Zhang","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"2026062512014234100_oyag194-B22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ejca.2016.02.010","article-title":"Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor","volume":"60","author":"Belum","year":"2016","journal-title":"Eur J Cancer"},{"key":"2026062512014234100_oyag194-B23","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1634\/theoncologist.2018-0128","article-title":"A case of nivolumab-induced bullous pemphigoid: review of dermatologic toxicity associated with programmed cell death protein-1\/programmed death ligand-1 inhibitors and recommendations for diagnosis and management","volume":"23","author":"Lopez","year":"2018","journal-title":"Oncologist"},{"key":"2026062512014234100_oyag194-B24","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/jid.2011.411","article-title":"Ionizing radiation: the good, the bad, and the ugly","volume":"132","author":"Ryan","year":"2012","journal-title":"J Invest Dermatol"},{"key":"2026062512014234100_oyag194-B25","doi-asserted-by":"publisher","first-page":"adv00164","DOI":"10.2340\/00015555-3514","article-title":"Skin microbiome in atopic dermatitis","volume":"100","author":"Edslev","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"2026062512014234100_oyag194-B26","doi-asserted-by":"publisher","first-page":"e1641387","DOI":"10.1080\/2162402X.2019.1641387","article-title":"Staphylococcal alpha-toxin tilts the balance between malignant and non-malignant CD4+ T cells in cutaneous T-cell lymphoma","volume":"8","author":"Bl\u00fcmel","year":"2019","journal-title":"Oncoimmunology"},{"key":"2026062512014234100_oyag194-B27","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.abd.2021.05.007","article-title":"Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital","volume":"97","author":"Ceglio","year":"2022","journal-title":"An Bras Dermatol"},{"key":"2026062512014234100_oyag194-B28","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.3390\/biomedicines13123044","article-title":"Cutaneous adverse events of tyrosine kinase inhibitors in endocrine tumors: clinical features, mechanisms, and management strategies","volume":"13","author":"Marino","year":"2025","journal-title":"Biomedicines"},{"key":"2026062512014234100_oyag194-B29","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1111\/jdv.16159","article-title":"Outpatient dermatology consultations for oncology patients with acute dermatologic adverse events impact anticancer therapy interruption: a retrospective study","volume":"34","author":"Barrios","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026062512014234100_oyag194-B30","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.jaad.2019.09.026","article-title":"Dermatology consultation reduces interruption of oncologic management among hospitalized patients with immune-related adverse events: a retrospective cohort study","volume":"82","author":"Chen","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"2026062512014234100_oyag194-B31","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1007\/s00520-023-08116-4","article-title":"The role of dermocosmetics in the management of cancer-related skin toxicities: international expert consensus","volume":"31","author":"Dreno","year":"2023","journal-title":"Support Care Cancer"},{"key":"2026062512014234100_oyag194-B32","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1093\/jjco\/hyy045","article-title":"Efficacy of heparinoid moisturizer as a prophylactic agent for radiation dermatitis following radiotherapy after breast-conserving surgery: a randomized controlled trial","volume":"48","author":"Sekiguchi","year":"2018","journal-title":"Jpn J Clin Oncol"},{"key":"2026062512014234100_oyag194-B33","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s00520-010-0851-8","article-title":"Skin care management in cancer patients: an evaluation of quality of life and tolerability","volume":"19","author":"Haley","year":"2011","journal-title":"Support Care Cancer"},{"key":"2026062512014234100_oyag194-B34","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/j.1468-3083.2006.02080.x","article-title":"Impact of cosmetic care on quality of life in breast cancer patients during chemotherapy and radiotherapy: an initial randomized controlled study","volume":"21","author":"Titeca","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026062512014234100_oyag194-B35","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1177\/0300891619867844","article-title":"Camouflage makeup improves quality of life in cancer patients with treatment-related skin changes","volume":"106","author":"Wakeda","year":"2020","journal-title":"Tumori"},{"key":"2026062512014234100_oyag194-B36","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.4143\/crt.2017.435","article-title":"The impact of skin problems on the quality of life in patients treated with anticancer agents: a cross-sectional study","volume":"50","author":"Lee","year":"2018","journal-title":"Cancer Res Treat"},{"key":"2026062512014234100_oyag194-B37","doi-asserted-by":"publisher","first-page":"3ss","DOI":"10.36849\/jdd.6229","article-title":"US Cutaneous Oncodermatology Management (USCOM): a practical algorithm","volume":"20","author":"Lacouture","year":"2021","journal-title":"J Drugs Dermatol"},{"key":"2026062512014234100_oyag194-B38","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.annonc.2020.11.005","article-title":"Prevention and management of dermatological toxicities related to anticancer agents: ESMO clinical practice guidelines\u22c6","volume":"32","author":"Lacouture","year":"2021","journal-title":"Ann Oncol"},{"key":"2026062512014234100_oyag194-B39","doi-asserted-by":"publisher","first-page":"771","DOI":"10.2165\/00128071-200304110-00005","article-title":"Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders","volume":"4","author":"Lod\u00e9n","year":"2003","journal-title":"Am J Clin Dermatol"},{"key":"2026062512014234100_oyag194-B40","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3390\/ijms19010070","article-title":"Anti-inflammatory and skin barrier repair effects of topical application of some plant oils","volume":"19","author":"Lin","year":"2017","journal-title":"Int J Mol Sci"},{"key":"2026062512014234100_oyag194-B41","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1200\/JCO.2008.21.7828","article-title":"Skin toxicity evaluation protocol with panitumumab (STEPP), a phase II, open-label, randomized trial evaluating the impact of a pre-emptive skin treatment regimen on skin toxicities and quality of life in patients with metastatic colorectal cancer","volume":"28","author":"Lacouture","year":"2010","journal-title":"J Clin Oncol"},{"key":"2026062512014234100_oyag194-B42","doi-asserted-by":"publisher","first-page":"279","DOI":"10.4103\/0019-5154.182427","article-title":"Moisturizers: the slippery road","volume":"61","author":"Sethi","year":"2016","journal-title":"Indian J Dermatol"},{"key":"2026062512014234100_oyag194-B43","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1562\/0031-8655(1999)069&lt;0317:caiuis&gt;2.3.co;2","article-title":"Stratum corneum lipid abnormalities in UVB-irradiated skin","volume":"69","author":"Meguro","year":"1999","journal-title":"Photochem Photobiol"},{"key":"2026062512014234100_oyag194-B44","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.biochi.2009.04.001","article-title":"Ceramide biosynthesis in keratinocyte and its role in skin function","volume":"91","author":"Mizutani","year":"2009","journal-title":"Biochimie"},{"key":"2026062512014234100_oyag194-B45","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/s0738-081x(02)00373-5","article-title":"The skin barrier and use of moisturizers in atopic dermatitis","volume":"21","author":"Lod\u00e9n","year":"2003","journal-title":"Clin Dermatol"},{"key":"2026062512014234100_oyag194-B46","doi-asserted-by":"publisher","first-page":"53","DOI":"10.4103\/ijd.ijd_991_22","article-title":"The efficacy of moisturisers containing ceramide compared with other moisturisers in the management of atopic dermatitis: a systematic literature review and meta-analysis","volume":"68","author":"Nugroho","year":"2023","journal-title":"Indian J Dermatol"},{"key":"2026062512014234100_oyag194-B47","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.3390\/ijms14011132","article-title":"The role of altered nucleotide excision repair and UVB-induced DNA damage in melanomagenesis","volume":"14","author":"Budden","year":"2013","journal-title":"Int J Mol Sci"},{"key":"2026062512014234100_oyag194-B48","first-page":"445","article-title":"Photoaging: the role of oxidative stress","volume":"145","author":"Burke","year":"2010","journal-title":"G Ital Dermatol Venereol"},{"key":"2026062512014234100_oyag194-B49","doi-asserted-by":"publisher","first-page":"821","DOI":"10.2165\/11592780-000000000-00000","article-title":"Drug-induced photosensitivity: culprit drugs, management and prevention","volume":"34","author":"Drucker","year":"2011","journal-title":"Drug Saf"},{"key":"2026062512014234100_oyag194-B50","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1046\/j.1523-1747.2002.01742.x","article-title":"Epidermal Langerhans cell depletion after artificial ultraviolet B irradiation of human skin in vivo: apoptosis versus migration","volume":"118","author":"K\u00f6lgen","year":"2002","journal-title":"J Invest Dermatol"},{"key":"2026062512014234100_oyag194-B51","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2147\/NSA.S19419","article-title":"Titanium dioxide and zinc oxide nanoparticles in sunscreens: focus on their safety and effectiveness","volume":"4","author":"Smijs","year":"2011","journal-title":"Nanotechnol Sci Appl"},{"key":"2026062512014234100_oyag194-B52","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.tox.2004.06.043","article-title":"Endocrine activity and developmental toxicity of cosmetic UV filters\u2014an update","volume":"205","author":"Schlumpf","year":"2004","journal-title":"Toxicology"},{"key":"2026062512014234100_oyag194-B53","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1001\/jama.2019.20747","article-title":"Effect of sunscreen application on plasma concentration of sunscreen active ingredients: a randomized clinical trial","volume":"323","author":"Matta","year":"2020","journal-title":"JAMA"},{"key":"2026062512014234100_oyag194-B54","doi-asserted-by":"publisher","first-page":"e11-8","DOI":"10.1016\/S1470-2045(12)70413-8","article-title":"Cutaneous toxicities of RAF inhibitors","volume":"14","author":"Anforth","year":"2013","journal-title":"Lancet Oncol"},{"key":"2026062512014234100_oyag194-B55","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1111\/j.1365-4632.2010.04474.x","article-title":"Ultraviolet radiation and skin cancer","volume":"49","author":"Narayanan","year":"2010","journal-title":"Int J Dermatol"},{"key":"2026062512014234100_oyag194-B56","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.jaad.2004.06.027","article-title":"Oral polypodium leucotomos extract decreases ultraviolet-induced damage of human skin","volume":"51","author":"Middelkamp-Hup","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"2026062512014234100_oyag194-B57","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/phpp.12597","article-title":"DNA repair enzymes in sunscreens and their impact on photoageing-A systematic review","volume":"36","author":"Luze","year":"2020","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"2026062512014234100_oyag194-B58","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/phpp.12776","article-title":"Photoprotection by clothing: a review","volume":"38","author":"Boothby-Shoemaker","year":"2022","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"2026062512014234100_oyag194-B59","doi-asserted-by":"publisher","first-page":"e34934","DOI":"10.7759\/cureus.34934","article-title":"Attitudes, behaviors, and risks of sun protection to prevent skin cancer amongst children, adolescents, and adults","volume":"15","author":"Raymond-Lezman","year":"2023","journal-title":"Cureus"},{"key":"2026062512014234100_oyag194-B60","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1177\/10600280231197459","article-title":"Targeted therapies for previously \u201cundruggable\u201d KRAS-mutated non-small cell lung cancer: a review of sotorasib and adagrasib","volume":"58","author":"Mausey","year":"2024","journal-title":"Ann Pharmacother"},{"key":"2026062512014234100_oyag194-B61","doi-asserted-by":"publisher","first-page":"100661","DOI":"10.1016\/j.jtocrr.2024.100661","article-title":"Prolonged cancer control with adagrasib in patients with metastatic, KRASG12C-mutated NSCLC after sotorasib-induced hepatotoxicity: a case report","volume":"5","author":"Stratton","year":"2024","journal-title":"JTO Clin Res Rep"},{"key":"2026062512014234100_oyag194-B62","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s00520-011-1197-6","article-title":"Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities","volume":"19","author":"Lacouture","year":"2011","journal-title":"Support Care Cancer"},{"key":"2026062512014234100_oyag194-B63","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1016\/S1556-0864(25)00201-1","article-title":"Safety and clinical activity of daraxonrasib (RMC-6236) in RAS mutant non-small cell lung cancer (NSCLC)","volume":"20","author":"Punekar","year":"2025","journal-title":"J Thorac Oncol"},{"key":"2026062512014234100_oyag194-B64","author":"Douthat","year":"2026"},{"key":"2026062512014234100_oyag194-B65","doi-asserted-by":"publisher","first-page":"271","DOI":"10.4103\/0019-5154.131398","article-title":"Dermatological side effects of epidermal growth factor receptor inhibitors: \u201cPRIDE\u201d complex","volume":"59","author":"Madke","year":"2014","journal-title":"Indian J Dermatol"},{"key":"2026062512014234100_oyag194-B66","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.jaad.2020.03.132","article-title":"Immune checkpoint inhibitor-related dermatologic adverse events","volume":"83","author":"Geisler","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"2026062512014234100_oyag194-B67","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1007\/s12094-018-1953-x","article-title":"Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology","volume":"21","author":"Gr\u00e1valos","year":"2019","journal-title":"Clin Transl Oncol"},{"key":"2026062512014234100_oyag194-B68","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.jaad.2018.10.062","article-title":"Inflammatory eruptions associated with immune checkpoint inhibitor therapy: a single-institution retrospective analysis with stratification of reactions by toxicity and implications for management","volume":"80","author":"Coleman","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"2026062512014234100_oyag194-B69","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.cptl.2013.09.008","article-title":"The pharmacist role in dermatologic care","volume":"6","author":"Fabbro","year":"2014","journal-title":"Currents in Pharmacy Teaching and Learning"},{"key":"2026062512014234100_oyag194-B70","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1188\/12.CJON.278-285","article-title":"A feasibility study of low-cost, self-administered skin care interventions in patients with head and neck cancer receiving chemoradiation","volume":"16","author":"Mannix","year":"2012","journal-title":"Clin J Oncol Nurs"},{"key":"2026062512014234100_oyag194-B71","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1001\/jamainternmed.2018.0447","article-title":"Association of a smartphone application with medication adherence and blood pressure control: the MedISAFE-BP randomized clinical trial","volume":"178","author":"Morawski","year":"2018","journal-title":"JAMA Intern Med"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/oncolo\/advance-article-pdf\/doi\/10.1093\/oncolo\/oyag194\/68446005\/oyag194.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/31\/7\/oyag194\/68446005\/oyag194.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/31\/7\/oyag194\/68446005\/oyag194.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T16:01:47Z","timestamp":1782403307000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/doi\/10.1093\/oncolo\/oyag194\/8699602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":71,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,6,6]]}},"URL":"https:\/\/doi.org\/10.1093\/oncolo\/oyag194","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,6,1]]},"article-number":"oyag194"}}